USA: In a post hoc analysis of the ADJUST-T1D trial, adults with type 1 diabetes receiving once-weekly semaglutide 1 mg showed a significant reduction in total daily insulin dose by 4 weeks, ...

How to Inject Semaglutide This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ...

Learn more about GLP-1 pills and how they may be more convenient and cost-effective than the injections.

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

Please provide your email address to receive an email when new articles are posted on . Adults receiving nimacimab plus semaglutide had a 2.95 percentage point greater weight loss than semaglutide ...

For the primary endpoint, orforglipron lowered A1C by 2.2% vs. 1.4% with oral semaglutide at the highest doses Participants taking the highest dose of orforglipron lost an average of 19.7 lbs (9.2%) ...

Semaglutide is a glucagon-like peptide-1 receptor (GLP-1) medication primarily used to manage obesity and diabetes. The U.S. Food and Drug Administration (FDA) also has approved it under the brand ...

Semaglutide 2.4 mg improves insulin sensitivity and glycemic outcomes in adolescents with obesity, according to a secondary analysis of STEP TEENS.